A cardiologist by training, Nathan has been with Frazier Healthcare Partners since 1999. He has led exited investments including BARRX (acquired by Covidien), Zeltiq (NASDAQ: ZLTQ), Glaukos (NASDAQ: GKOS), Packaging Coordinators Inc. (PCI) (acquired by Kohlberg and Company), Abode Healthcare (acquired by Tailwind Capital), Silvergate Pharma (acquired by CutisPharma), Powervision (acquired by Alcon), and The CORE Institute (acquired by Audax Group and Linden Capital Partners). He currently serves on the boards of Adare Pharma Services, Apollo Intelligence, CPS Solutions, Caravel Autism Health, EPTAM Precision, and HOPCO/CORE Orthopedics. He previously served on the PRI Investment Committee of the Bill and Melinda Gates Foundation.
Prior to joining Frazier, Nathan was an Associate Professor of Medicine and the Director of the Cardiovascular Outcomes Research Center (CORC) at the University of Washington.
Dr. Every earned an M.D. from Emory University School of Medicine and a Masters of Public Health (M.P.H.) from the University of Washington.
Emory University School of Medicine (M.D.)
University of Washington School of Public Health (M.P.H.)
University of Pennsylvania (B.A.)